AngioDynamics to Present at 33rd Annual J.P. Morga
Post# of 301275
ALBANY, N.Y., Jan. 6, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq: ANGO ), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to present at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015, at 2:30 p.m. (PT). The conference will be held at the Westin St. Francis Hotel in San Francisco, Calif.
A live audio and/or webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm . The replay will be available for 90 days after the event.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com .
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Company Contact: AngioDynamics, Inc. Mark Frost, CFO (800) 772-6446 x1981 Investor Relations Contacts: EVC Group, Inc. Chris Dailey/Robert Jones (646) 445-4801; (646) 201-5447 ; Media Contact: EVC Group, Inc. Dave Schemelia (646) 201-5431
(0)
(0)